These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1695207)

  • 1. Diversity of Francisella tularensis antigens recognized by human T lymphocytes.
    Surcel HM
    Infect Immun; 1990 Aug; 58(8):2664-8. PubMed ID: 1695207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.
    Surcel HM; Syrjälä H; Karttunen R; Tapaninaho S; Herva E
    Infect Immun; 1991 Jun; 59(6):1948-53. PubMed ID: 1674737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals.
    Sjöstedt A; Sandström G; Tärnvik A
    J Clin Microbiol; 1990 Jan; 28(1):43-8. PubMed ID: 1688874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals.
    Surcel HM; Sarvas M; Helander IM; Herva E
    Microb Pathog; 1989 Dec; 7(6):411-9. PubMed ID: 2622330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signatures of T cells as correlates of immunity to Francisella tularensis.
    Eneslätt K; Normark M; Björk R; Rietz C; Zingmark C; Wolfraim LA; Stöven S; Sjöstedt A
    PLoS One; 2012; 7(3):e32367. PubMed ID: 22412866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.
    Yu JJ; Goluguri T; Guentzel MN; Chambers JP; Murthy AK; Klose KE; Forsthuber TG; Arulanandam BP
    Clin Vaccine Immunol; 2010 Feb; 17(2):215-22. PubMed ID: 20016043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.
    Sjöstedt A; Eriksson M; Sandström G; Tärnvik A
    Immunology; 1992 Aug; 76(4):584-92. PubMed ID: 1356911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.
    Sandström G; Tärnvik A; Wolf-Watz H
    J Clin Microbiol; 1987 Apr; 25(4):641-4. PubMed ID: 3494744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis.
    Sjöstedt A; Sandström G; Tärnvik A; Jaurin B
    J Immunol; 1990 Jul; 145(1):311-7. PubMed ID: 1694206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.
    Karttunen R; Surcel HM; Andersson G; Ekre HP; Herva E
    J Clin Microbiol; 1991 Apr; 29(4):753-6. PubMed ID: 1909711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
    Poquet Y; Kroca M; Halary F; Stenmark S; Peyrat MA; Bonneville M; Fournié JJ; Sjöstedt A
    Infect Immun; 1998 May; 66(5):2107-14. PubMed ID: 9573096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological markers that correlate with protection immunity against tularemia infection.
    Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA
    Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.
    Valentino MD; Hensley LL; Skrombolas D; McPherson PL; Woolard MD; Kawula TH; Frelinger JA; Frelinger JG
    Mol Immunol; 2009 May; 46(8-9):1830-8. PubMed ID: 19233475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.
    Tärnvik A; Holm SE
    Infect Immun; 1978 Jun; 20(3):698-704. PubMed ID: 307538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the antigenic fractions of the outer membrane of Francisella tularensis on the T-cell immunity indices].
    Skatov DV; Galaktionov VG; Semenkova LN; Khlebnikov VS
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):100-3. PubMed ID: 7941852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions.
    Sandström G; Tärnvik A; Wolf-Watz H; Löfgren S
    Infect Immun; 1984 Jul; 45(1):101-6. PubMed ID: 6203835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
    Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
    Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity against Francisella tularensis after natural infection.
    Koskela P; Herva E
    Scand J Infect Dis; 1980; 12(4):281-7. PubMed ID: 7006062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection.
    Ericsson M; Sandström G; Sjöstedt A; Tärnvik A
    J Infect Dis; 1994 Jul; 170(1):110-4. PubMed ID: 8014484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.